Overview

Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate efficacy and safety of DP-R207 in patients with primary hypercholesterolemia.
Phase:
Phase 3
Details
Lead Sponsor:
Alvogen Korea
Treatments:
Ezetimibe
Rosuvastatin Calcium